Michael Arvanitis, MD
Colon & Rectal Surgery · Eatontown, NJNPI 1144243684
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,979 of the $2,220 with a category attached, or 89.1%. 10 manufacturers reported payments, led by THD America, Inc. at 35.9% of the total. Reporting peaked in 2021 at $733 and has fallen 69.1% since, to $226 in 2025.
Across 31 payments — averaging $71.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- THD America, Inc.$798
- Intuitive Surgical$427
- Johnson & Johnson$423
- Davol Inc.$220
- Teleflex LLC$199
- Kerecis Limited$65
- plus $89 from 4 others
What the payments were for
- Food & beverage$1,97989%
- Education$24111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| THD America, Inc. | 7 | $798 |
| Intuitive Surgical | 4 | $427 |
| Johnson & Johnson | 8 | $423 |
| Davol Inc. | 3 | $220 |
| Teleflex LLC | 1 | $199 |
| Kerecis Limited | 2 | $65 |
| Medtronic | 3 | $47 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,220 in reported general payments places this provider in the 55th percentile of 86 colon & rectal surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 12 | $10,012 |
| Mesalamine | 13 | $4,796 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 19 | $3,030 |
| Colestipol Hcl | 28 | $945 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 24 | $479 |
| Oxycodone Hcl | 28 | $140 |
| Metronidazole | 43 | $137 |
| Neomycin Sulfate | 24 | $135 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $105 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Eatontown
- Paul KolarsickEatontown$6K
- Roy DressnerEatontown$5K
- Steven Lee-KongHackensack$55K
- Ashlee Godshalk RugglesPennington$44K
- John BerryPennington$36K
- Thomas LakeOakhurst$15K
- Glenn ParkerOakhurst$14K
- Daniel FeingoldNew Brunswick$14K
- Kulvir NandraGlen Ridge$12K
- Michele MalitHolmdel$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.